NO vascular control in Duchenne muscular dystrophy

被引：28
|
作者：
Crosbie, RH [1 ]
机构：
[1] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA
来源：
NATURE MEDICINE | 2001年 / 7卷 / 01期
关键词：
D O I：
10.1038/83309
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A new investigation into Duchenne muscular dystrophy (DMD) pathogenesis suggests that at least part of the muscle degeneration observed in DMD patients may result from the reduced production of muscle membrane-associated neuronal nitric oxide synthase. This reduction may lead to impaired regulation of the vasoconstrictor response and eventual muscle damage.
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [1] NO vascular control in Duchenne muscular dystrophy
    Rachelle H. Crosbie
    Nature Medicine, 2001, 7 : 27 - 29
  • [2] Vascular-targeted therapies for Duchenne muscular dystrophy
    James P Ennen
    Mayank Verma
    Atsushi Asakura
    Skeletal Muscle, 3
  • [3] Vascular-targeted therapies for Duchenne muscular dystrophy
    Ennen, James P.
    Verma, Mayank
    Asakura, Atsushi
    SKELETAL MUSCLE, 2013, 3
  • [4] Nefopam for pain control in Duchenne muscular dystrophy
    Brain, Amanda
    Banting, Mark
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (E3) : e778 - e779
  • [5] Duchenne muscular dystrophy
    Nature Reviews Disease Primers, 7 (1)
  • [6] Duchenne muscular dystrophy
    Yiu, Eppie M.
    Kornberg, Andrew J.
    NEUROLOGY INDIA, 2008, 56 (03) : 236 - 247
  • [7] Duchenne Muscular Dystrophy
    Kernich, Catherine A.
    NEUROLOGIST, 2009, 15 (06) : 373 - +
  • [8] Duchenne Muscular Dystrophy
    Sanders, Mark A.
    Towbin, Richard B.
    Schaefer, Carrie M.
    Li, Yinan
    Towbin, Alexander J.
    APPLIED RADIOLOGY, 2023, 52 (02) : 33 - 35
  • [9] Duchenne muscular dystrophy
    Duan, Dongsheng
    Goemans, Nathalie
    Takeda, Shin'ichi
    Mercuri, Eugenio
    Aartsma-Rus, Annemieke
    NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
  • [10] Duchenne muscular dystrophy
    Biggar, WD
    PEDIATRICS IN REVIEW, 2006, 27 (03) : 83 - 88
12345